Clinical Trial Update: A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 trial update evaluates total exposure of NN5401 (insulin degludec/insulin aspart) in children, adolescents, and adults with Type 1 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN5401 (Insulin Degludec/Insulin Aspart) (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED